Angina, Unstable Clinical Trial
Official title:
Prevention and Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy
Verified date | June 2021 |
Source | Catcronic Salut SL |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cardiac rehabilitation after an acute coronary syndrome is recognised in the latest guidelines and recommendations published by the major scientific societies as a class I indication. Despite this evidence, the number of patients entering such programmes in Europe is still around 30%. The present study aims to validate a new comprehensive Telerehabilitation System to provide support for cardiac rehabilitation, to optimize it and to test its usefulness in terms of improving adherence to physical exercise and cardiovascular risk parameters.
Status | Completed |
Enrollment | 67 |
Est. completion date | December 7, 2020 |
Est. primary completion date | December 7, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 72 Years |
Eligibility | Inclusion Criteria: - Signed informed consent - Patients after uncomplicated acute coronary syndrome of both sexes. - Patients completing a maximal or symptom-limited CPET without angina or electrical ischaemia. - Age equal to or less than 72 years. Exclusion Criteria: - Refusal of informed consent - Advanced biological age. - Kidney failure (GFR < 30ml/min/1.73 m2). - Liver failure (GOT >2 times normal value). - Ejection fraction less than 50%. - Uncontrolled blood pressure (>140/90 mmHg). - Uncontrolled heart failure. - Dissecting aortic aneurysm. - Uncontrolled ventricular tachycardia or other dangerous ventricular arrhythmias. - Aortic or mitral valve disease. - Recent systemic or pulmonary embolism. - Active or recent thrombophlebitis. - Acute infectious diseases. - Uncontrolled supraventricular arrhythmias or tachycardia. - Repeated or frequent ventricular ectopic activity. - Moderate pulmonary hypertension. - Ventricular aneurysm. - Uncontrolled diabetes, thyrotoxicosis, myxedema, - Conduction disorders such as: complete atrioventricular block. Left bundle branch block. - Wolf-Parkinson-White syndrome. - Fixed rate pacing. - Severe anaemia. - Psychoneurotic disorders. - Neuromuscular, musculoskeletal and arthritic disorders that may limit activity. may limit activity. |
Country | Name | City | State |
---|---|---|---|
Spain | Ernesto Dalli Peydró | Valencia | |
Spain | Hospital Politécnico Universitario La Fe | Valencia |
Lead Sponsor | Collaborator |
---|---|
Catcronic Salut SL |
Spain,
Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, Iliou MC, Pedretti RF, Schmid JP, Vigorito C, Voller H, Wilhelm M, Piepoli MF, Bjarnason-Wehrens B, Berger T, Cohen-Solal A, Cornelissen V, Dendale P, Doehner W, Gaita D, Gevaert AB, Kemps H, Kraenkel N, Laukkanen J, Mendes M, Niebauer J, Simonenko M, Zwisler AO. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020 Apr 7. pii: 2047487320913379. doi: 10.1177/2047487320913379. [Epub ahead of print] — View Citation
Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, Van Craenenbroeck E, Van Driessche N, Dendale P. Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial. J Med Internet Res. 2015 Jul 23;17(7):e185. doi: 10.2196/jmir.4799. — View Citation
Frederix I, Vanhees L, Dendale P, Goetschalckx K. A review of telerehabilitation for cardiac patients. J Telemed Telecare. 2015 Jan;21(1):45-53. doi: 10.1177/1357633X14562732. Epub 2014 Dec 4. Review. — View Citation
Reibis R, Salzwedel A, Abreu A, Corra U, Davos C, Doehner W, Doherty P, Frederix I, Hansen D, Christine Iliou M, Vigorito C, Völler H; Secondary Prevention and Rehabilitation of the European Association of Preventive Cardiology (EAPC). The importance of return to work: How to achieve optimal reintegration in ACS patients. Eur J Prev Cardiol. 2019 Sep;26(13):1358-1369. doi: 10.1177/2047487319839263. Epub 2019 Apr 10. Review. — View Citation
Scherrenberg M, Falter M, Dendale P. Providing comprehensive cardiac rehabilitation during and after the COVID-19 pandemic. Eur J Prev Cardiol. 2021 May 14;28(5):520-521. doi: 10.1093/eurjpc/zwaa107. — View Citation
Thomas RJ, Beatty AL, Beckie TM, Brewer LC, Brown TM, Forman DE, Franklin BA, Keteyian SJ, Kitzman DW, Regensteiner JG, Sanderson BK, Whooley MA. Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. Circulation. 2019 Jul 2;140(1):e69-e89. doi: 10.1161/CIR.0000000000000663. Epub 2019 May 13. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Physical activity derived from the International Physical Activity questionnaire (IPAQ) | self-reported physical activity measured in metabolic equivalents (MET-min/week) Minimum value: 0, maximum value 19,278. Higher scores mean a better outcome. | 10 months | |
Secondary | Maximal oxygen uptake | Maximal oxygen uptake during the final 30 seconds of the cardiopulmonary exercise testing (CPET) (ml/kg/min ) | 10 months | |
Secondary | Maximal heart rate | Maximal heart rate at the end of the exercise testing (bpm) | 10 months | |
Secondary | Exercise time | stress test duration (minutes) | 10 months | |
Secondary | Lipid parameters | Total cholesterol (mg/dL), HDL cholesterol (mg/dL), LDL cholesterol (mg/dL), Non-HDL cholesterol (mg/dL), Triglycerides (mg/dL), Apolipoprotein B/Apolipoprotein A-I ratio | 10 months | |
Secondary | Glycosylated haemoglobin | Percentage | 10 months | |
Secondary | Weight | Kg | 4 and 10 months | |
Secondary | Waist circumference | waist circumference change (cm) | 4 and 10 months | |
Secondary | Visceral fat | Percentage | 4 and 10 months | |
Secondary | energy expenditure obtained from the International Physical Activity questionnaire (IPAQ) questionaire | Kcal/week | 10 months | |
Secondary | High level of effort obtained from the International Physical Activity questionnaire (IPAQ) questionaire | Percentage | 10 months | |
Secondary | Total score of Adherence to Mediterranean Diet obtained from the Prevention with Mediterranean Diet questionnaire (PREDIMED). | Units. Minimum value: 0, maximum value: 14. Higher scores mean a better outcome. | 10 months | |
Secondary | High level of Adherence to Mediterranean Diet obtained from the Prevention with Mediterranean Diet questionnaire (PREDIMED) | percentage. Minimum value: 0%, maximum value: 100%. Higher scores mean a better outcome. | 10 months | |
Secondary | Global score of emotional distress obtained from the Hospital Anxiety and Depression Scale (HADS) | Units. Minimum value: 0, maximum value: 14. Lower scores mean a better outcome. | 10 months | |
Secondary | Anxiety subscale of emotional distress obtained from the Hospital Anxiety and Depression Scale (HADS) | Units. Minimum value: 0, maximum value: 7. Lower scores mean a better outcome. | 10 months | |
Secondary | Depression subscale of Emotional distress obtained from the Hospital Anxiety and Depression Scale (HADS) | Units. Minimum value: 0, maximum value: 7. Lower scores mean a better outcome. | 10 months | |
Secondary | Global index of the health-related quality of life obtained from the European Quality of Life questionnaire (EuroQol-5D) | Units. Minimum value: 0, maximum value: 1. Higher scores mean a better outcome. | 10 months | |
Secondary | Health status obtained from the European Quality of Life questionnaire (EuroQol-5D) | Units. Minimum value: 0, maximum value: 100. Higher scores mean a better outcome. | 10 months | |
Secondary | smoking cessation | percentage | 10 months | |
Secondary | Time to start the rehabilitation programme after discharge from hospital | days | 10 months | |
Secondary | Returning to work | days | 10 months | |
Secondary | Pulse wave velocity | m/s | 10 months | |
Secondary | User's experience from the System Usability Scale (SUS) score | Units. Minimum value: 0, maximum value: 100. Higher scores mean a better outcome. | 10 months | |
Secondary | Cost-effectiveness analysis | net cost divided by changes in health outcomes | 10 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Completed |
NCT05466825 -
Global Cardiovascular Risk Consortium
|
||
Completed |
NCT02290080 -
Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
|
Phase 3 | |
Completed |
NCT00692991 -
Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
|
N/A | |
Recruiting |
NCT03715582 -
Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes
|
Phase 3 | |
Recruiting |
NCT02760732 -
Drug Eluting Balloon for Treatment of Unstable Angina
|
N/A | |
Completed |
NCT01331707 -
DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population
|
Phase 4 | |
Completed |
NCT00091507 -
IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
|
Phase 3 | |
Completed |
NCT00269893 -
A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty
|
Phase 3 | |
Completed |
NCT02983123 -
One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome
|
||
Recruiting |
NCT06075602 -
COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
|
||
Completed |
NCT02925923 -
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
|
Phase 2 | |
Completed |
NCT00354328 -
Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
|
||
Completed |
NCT00269906 -
A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty
|
Phase 3 | |
Completed |
NCT03518645 -
Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds
|
N/A | |
Completed |
NCT00133003 -
Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
|
Phase 4 | |
Completed |
NCT01617863 -
Hemodynamics During the Soccer Championship 2012
|
N/A | |
Completed |
NCT02581540 -
Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin
|
||
Completed |
NCT00905671 -
Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study
|
Phase 4 | |
Terminated |
NCT00435487 -
Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
|
Phase 4 |